Trial Profile
Contrast echocardiography assessment of the early effect of an anti-angiogenic treatment in advanced renal cell carcinoma [Evaluation de l'echographie de contraste pour l'appreciation precoce de l'effet d'un traitement anti-angiogenique sur le carcinome renal avance]
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2011
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Sorafenib (Primary) ; Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- Acronyms CREIN
- 31 Aug 2011 New trial record